NKY(SZ:300109) Sou Hu Cai Jing·2025-05-12 09:29Group 1 - The core viewpoint of the articles highlights the performance and valuation of Xin Kai Yuan, which closed at 16.82 yuan on May 12, with a 6.25% increase, resulting in a rolling PE ratio of 26.41, the lowest in 25 days, and a total market capitalization of 8.153 billion yuan [1] - Xin Kai Yuan ranks 77th in the chemical products industry, which has an average PE ratio of 43.30 and a median of 39.16 [1][2] - The company experienced a net inflow of 41.4149 million yuan in main funds on May 12, with a total inflow of 85.9945 million yuan over the past five days [1] Group 2 - Xin Kai Yuan's main business focuses on fine chemicals and precision medicine, with key products including PVPK30, PVP-I, and various diagnostic services [1] - The latest financial results for Q1 2025 show that the company achieved an operating income of 325 million yuan, a year-on-year decrease of 17.69%, and a net profit of 80.4203 million yuan, down 33.75%, with a gross profit margin of 44.07% [1]